Provides telehealth-based medication-assisted treatment (MAT) for opioid use disorder, primarily using Suboxone® (buprenorphine/naloxone) to reduce cravings and manage withdrawal symptoms. The platform offers affordable, confidential care with 24/7 access to a dedicated clinical team, ensuring patients receive continuous support and personalized treatment without the need for in-person visits.
Funding
$67.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AHSFounders
Product
Problem
Individuals struggling with opioid use disorder often face barriers to accessing traditional treatment methods, including limited availability of specialists, the stigma associated with in-person visits, and the challenges of integrating treatment into daily life. This lack of accessible care contributes to high relapse rates and overdose fatalities.
Solution
Ophelia provides telehealth-based medication-assisted treatment (MAT) for opioid use disorder, delivering evidence-based care directly to patients in their homes. The platform connects patients with a dedicated clinical team, including clinicians, nurses, and care coordinators, who provide personalized treatment plans and continuous support. Ophelia primarily utilizes Suboxone (buprenorphine/naloxone) to reduce cravings and manage withdrawal symptoms, enabling patients to achieve stability and recovery without the need for frequent in-person visits. The service offers flexible scheduling, medication management, and ongoing support, ensuring that treatment fits seamlessly into the patient's lifestyle.
Target Audience
Ophelia's primary audience includes individuals with opioid use disorder seeking accessible, affordable, and confidential treatment, as well as healthcare providers and organizations looking to expand their addiction treatment services.
Features
- Online consultations with licensed clinicians via video calls
- Prescription and management of Suboxone (buprenorphine/naloxone)
- 24/7 access to a dedicated care team for continuous support
- Medication for symptoms related to withdrawal during induction, such as nausea or trouble sleeping, and medication for depressive, anxiety, and insomnia disorders
- Integration with local pharmacies for convenient prescription fulfillment
- Personalized treatment plans tailored to individual patient needs
- Transparent referral reporting to provide partners clarity and better outcomes for patients